InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Cannon, Gillian. Officer active across 1 company, notably Xenon Pharmaceuticals Inc.. Cumulatively, 6 disclosures have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €39k. History available since 5 June 2026. The latest transaction was disclosed on 5 June 2026 (10 - Acquisition or disposition in the public market). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Gillian Cannon is a declarant linked to Xenon Pharmaceuticals Inc. (XNAS), where she is Director of Issuer. Across 6 filings in total, the sampled recent filings run from 2026-06-05 to 2026-06-09, with EUR 39321 of buys and EUR 0 of sells, and the most frequent transaction nature is 57 - Exercise of rights.